X-linked Lymphoproliferative Disease. 2B4 Molecules Displaying Inhibitory Rather Than Activating Function Are Responsible for the Inability of Natural Killer Cells to Kill Epstein-Barr Virus-infected Cells
Overview
General Medicine
Authors
Affiliations
2B4 is a surface molecule involved in activation of the natural killer (NK) cell-mediated cytotoxicity. It binds a protein termed Src homology 2 domain-containing protein (SH2D1A) or signaling lymphocyte activation molecule (SLAM)-associated protein (SAP), which in turn has been proposed to function as a regulator of the 2B4-associated signal transduction pathway. In this study, we analyzed patients with X-linked lymphoproliferative disease (XLP), a severe inherited immunodeficiency characterized by critical mutations in the SH2D1A gene and by the inability to control Epstein-Barr virus (EBV) infections. We show that, in these patients, 2B4 not only fails to transduce triggering signals, but also mediates a sharp inhibition of the NK-mediated cytolysis. Other receptors involved in NK cell triggering, including CD16, NKp46, NKp44, and NKp30, displayed a normal functional capability. However, their activating function was inhibited upon engagement of 2B4 molecules. CD48, the natural ligand of 2B4, is highly expressed on the surface of EBV(+) B cell lines. Remarkably, NK cells from XLP patients could not kill EBV(+) B cell lines. This failure was found to be the consequence of inhibitory signals generated by the interaction between 2B4 and CD48, as the antibody-mediated disruption of the 2B4-CD48 interaction restored lysis of EBV(+) target cells lacking human histocompatibility leukocyte antigen (HLA) class I molecules. In the case of autologous or allogeneic (HLA class I(+)) EBV(+) lymphoblastoid cell lines, restoration of lysis was achieved only by the simultaneous disruption of 2B4-CD48 and NK receptor-HLA class I interactions. Molecular analysis revealed that 2B4 molecules isolated from either XLP or normal NK cells were identical. As expected, in XLP-NK cells, 2B4 did not associate with SH2D1A, whereas similar to 2B4 molecules isolated from normal NK cells, it did associate with Src homology 2 domain-containing phosphatase 1.
Lentiviral vectors for precise expression to treat X-linked lymphoproliferative disease.
Ayoub P, Gensheimer J, Lathrop L, Juett C, Quintos J, Tam K Mol Ther Methods Clin Dev. 2024; 32(4):101323.
PMID: 39309261 PMC: 11415656. DOI: 10.1016/j.omtm.2024.101323.
Natural Killer Cell Engagers (NKCEs): a new frontier in cancer immunotherapy.
Zhang M, Lam K, Xu S Front Immunol. 2023; 14:1207276.
PMID: 37638058 PMC: 10450036. DOI: 10.3389/fimmu.2023.1207276.
Approaching hemophagocytic lymphohistiocytosis.
Chinnici A, Beneforti L, Pegoraro F, Trambusti I, Tondo A, Favre C Front Immunol. 2023; 14:1210041.
PMID: 37426667 PMC: 10324660. DOI: 10.3389/fimmu.2023.1210041.
Marchitto L, Benlarbi M, Prevost J, Laumaea A, Descoteaux-Dinelle J, Medjahed H mBio. 2023; 14(4):e0078923.
PMID: 37404017 PMC: 10470595. DOI: 10.1128/mbio.00789-23.
Human natural killer cells: Form, function, and development.
Mace E J Allergy Clin Immunol. 2022; 151(2):371-385.
PMID: 36195172 PMC: 9905317. DOI: 10.1016/j.jaci.2022.09.022.